- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Oleclumab (MEDI9447)
Total 41 results
-
AstraZenecaCompleted
-
University Health Network, TorontoRecruiting
-
MedImmune LLCCompletedNSCLC | Resectable | Early-stageUnited States, Canada, Switzerland, Italy, France, Portugal, Spain
-
Jules Bordet InstituteAstraZeneca; Institut CurieActive, not recruiting
-
Dana-Farber Cancer InstituteAstraZenecaCompletedMuscle Invasive Bladder CancerUnited States
-
AstraZenecaCompletedProstate Cancer | Metastatic Castration-Resistant Prostate Cancer (mCRPC)United States
-
MedImmune LLCActive, not recruitingCarcinoma, Non-Small-Cell LungUnited States, Korea, Republic of, Taiwan
-
Jules Bordet InstituteAstraZenecaActive, not recruitingTriple Negative Breast CancerFrance, Belgium
-
Assistance Publique Hopitaux De MarseilleActive, not recruitingNon-small Cell Lung CancerFrance
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Osteosarcoma | Refractory Osteosarcoma | Metastatic Osteosarcoma | Metastatic Angiosarcoma | Recurrent Dedifferentiated Liposarcoma | Metastatic Dedifferentiated Liposarcoma | Recurrent Angiosarcoma | Refractory Dedifferentiated LiposarcomaUnited States
-
MedImmune LLCTerminatedMetastatic Microsatellite-stable Colorectal CancerUnited States, Spain, France, Australia, Canada
-
AstraZenecaRecruitingTriple Negative Breast NeoplasmsUnited States, Korea, Republic of, Canada, Taiwan, United Kingdom, Poland
-
MedImmune LLCCompletedStage III Non-small Cell Lung Cancer | UnresectableUnited States, Canada, Italy, Spain, France, Hong Kong, Portugal, Taiwan, Poland
-
MedImmune LLCCompletedSolid TumorsUnited States, Korea, Republic of, Australia
-
AstraZenecaParexelRecruitingNon-small Cell Lung CancerHungary, United States, Italy, Belgium, Spain, France, Korea, Republic of, Taiwan, Turkey, Ireland, Portugal, Canada
-
MedImmune LLCCompletedAcute Myeloid Leukemia | Multiple Myeloma | Diffuse Large B-cell LymphomaUnited States, France, Korea, Republic of
-
AstraZenecaRecruitingNon-Small Cell Lung CancerChina, Australia, Korea, Republic of, Canada, Poland, Spain, Vietnam, Germany, Brazil, Italy, Japan, Taiwan, Thailand, United States, United Kingdom, Portugal, Turkey, France, Peru, Colombia, Russian Federation, Ukraine
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, France, Spain, Switzerland
-
AstraZenecaActive, not recruitingMetastatic Non-Small Cell Lung Cancer (NSCLC)United States, Spain, Belgium, Poland, Taiwan, Thailand, Korea, Republic of, Russian Federation, Austria
-
MedImmune LLCCompletedCarcinoma | Metastatic Pancreatic AdenocarcinomaUnited States, Spain, Australia, Norway
-
AstraZenecaCompletedAdvanced Solid Malignancies | Non-Small Cell Lung Cancer (NSCLC) | Metastatic Castrate-Resistant Prostate Carcinoma (mCRPC) | Colorectal Carcinoma (CRC)United States
-
University Health Network, TorontoAstraZenecaWithdrawnSquamous Cell Carcinoma of Head and Neck | Non-small Cell Lung Cancer | Pancreatic Ductal AdenocarcinomaCanada
-
University Health Network, TorontoAstraZenecaWithdrawnRenal Cell Carcinoma | Non Small Cell Lung CancerCanada
-
MedImmune LLCCompletedMetastatic Castration-resistant Prostate Cancer (mCRPC) | Small Cell Lung Cancer (SCLC) | Pancreatic Ductal Adenocarcinoma (PDAC) | Head and Neck Squamous Cell Carcinoma (HNSCC) | Colorectal Cancer (CRC) | Non Small Cell Lung Cancer Squamous (NSCLC-Sq)United States, Canada
-
M.D. Anderson Cancer CenterRecruitingBorderline Resectable Pancreatic Adenocarcinoma | Stage IA Pancreatic Cancer AJCC v8 | Stage IB Pancreatic Cancer AJCC v8 | Stage IIA Pancreatic Cancer AJCC v8 | Stage IIB Pancreatic Cancer AJCC v8 | Resectable Pancreatic AdenocarcinomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...AstraZenecaWithdrawnOropharynx Cancer | HPV-Related Carcinoma | HPV Positive Oropharyngeal Squamous Cell CarcinomaUnited States
-
MedImmune LLCCompletedHead and Neck Cancer | Human Papilloma VirusUnited States
-
MedImmune LLCTerminatedCancer | Solid Tumors | CTCLUnited States, France, Canada
-
MedImmune LLCWithdrawnMicrosatellite-stable Colorectal Cancer
-
National Institute of Allergy and Infectious Diseases...RecruitingChronic HIV InfectionUnited States
-
International AIDS Vaccine InitiativeNational Institute of Allergy and Infectious Diseases (NIAID); Access to Advanced...Not yet recruiting
-
International AIDS Vaccine Initiative3M; Polymun Scientific GmbH; Access to Advanced Health Institute (AAHI)Not yet recruiting
-
Valneva Austria GmbHRecruitingZika | Zika Virus InfectionUnited States
-
National Cancer Institute (NCI)NRG OncologyRecruitingStage III Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Unresectable Lung Non-Small Cell Carcinoma | Locally Advanced Lung Non-Small Cell Carcinoma | Locally Recurrent Lung Non-Small Cell CarcinomaUnited States
-
National Institute of Allergy and Infectious Diseases...Department of Health and Human Services; HIV Vaccine Trials Network; Inovio Pharmaceuticals and other collaboratorsActive, not recruiting
-
National Institute of Allergy and Infectious Diseases...Active, not recruitingHIV-1-infectionUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IV Anal Cancer AJCC v8 | Recurrent Cervical Carcinoma | Metastatic Malignant Neoplasm | Stage IV Penile Cancer AJCC v8 | Recurrent Malignant Neoplasm | Refractory Malignant Neoplasm | Stage IV Cervical Cancer AJCC v8 | Stage IVA Cervical Cancer AJCC v8 | Stage IVB Cervical Cancer AJCC v8 | Stage... and other conditionsUnited States
-
National Institute of Allergy and Infectious Diseases...Active, not recruiting
-
AstraZenecaActive, not recruitingNon-Small Cell Lung CancerFrance, Spain, United States, Canada, Korea, Republic of, Austria, Israel, Germany
-
National Institute of Allergy and Infectious Diseases...Fred Hutchinson Cancer Center; International AIDS Vaccine Initiative; HIV Vaccine... and other collaboratorsActive, not recruiting
-
National Institute of Allergy and Infectious Diseases...Duke University; National Institutes of Health (NIH); Department of Health and... and other collaboratorsNot yet recruiting